Compound Summary
Compound Information
Salbutamol
Compound Name: | Salbutamol |
Compound CID: | 2083 |
Synonyms: | Salbutamol albuterol 18559-94-9 Proventil Sultanol More... |
Iupac Name: | 4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol |
InChI: | InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3 |
InChIKey: | NDAUXUAQIAJITI-UHFFFAOYSA-N |
Canonical Smiles: | CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O |
Isomeric Smiles: | CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O |
Molecular Weight: | 239.31 |
Molecular Formula: | C13H21NO3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Salbutamol
Molecular Weight: | 239.31 |
Molecular Formula: | C13H21NO3 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 17 |
Complexity: | 227 |
Synonyms
Salbutamol
| Salbutamol | Salbutamol |
|---|---|
Salbutamol |
albuterol |
18559-94-9 |
Proventil |
Sultanol |
Volmax |
Broncovaleas |
Aerolin |
dl-Salbutamol |
dl-Albuterol |
Ventolin Inhaler |
Ventolin |
Proventil HFA |
Buventol |
Cobutolin |
Salbulin |
Salbuvent |
Saventol |
Ventoline |
Asmaven |
Salamol |
Spreor |
Asmol |
Sultanol N |
Proventil Inhaler |
Novosalmol |
Salbuhexal |
Salbutalan |
Salbutamolum |
Servitamol |
Ventiloboi |
Ventodisks |
Almotex |
Anebron |
Asmadil |
Asmanil |
Asmasal |
Asmatol |
Asmidon |
Bronter |
Bugonol |
Butamol |
Butohaler |
Butotal |
Butovent |
Dilatamol |
Farcolin |
Gerivent |
Grafalin |
Libretin |
Medolin |
Parasma |
Pneumolat |
Respolin |
Sabutal |
Salbetol |
Salbron |
Salbupur |
Salbusian |
Salbutan |
Salbutol |
Salbuven |
Sallbupp |
Salmaplon |
Salomol |
Salvent |
Suprasma |
Theosal |
Tobybron |
Vencronyl |
Ventamol |
Ventilan |
Zaperin |
Bumol |
Mozal |
Respax |
Suxar |
Asthalin |
Alti-Salbutamol |
Broncho-Spray |
4-2-(tert-Butylamino)-1-hydroxyethyl-2-(hydroxymethyl)phenol |
Salbu-Fatol |
Buto-Asma |
Asmol Uni-Dose |
Ventolin Rotacaps |
Salbu-BASF |
Salbutamol Sulphate |
Volare easi-breathe |
Arubendol-Salbutamol |
Volare albuterol HFA |
ALBUTEROL (+/-) |
AH 3365 |
(l)-albuterol |
4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol |
AccuNeb |
2-(tert-Butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol |
alpha-(tert-Butylamino)methyl-4-hydroxy-m-xylene-alpha,alpha-diol |
Proventil (TN) |
Salbutamol (hemisulfate) |
MFCD00148978 |
1-(tert-Butylaminomethyl)-4-hydroxy-m-xylene-alpha1,alpha3-diol |
alpha-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha-diol |
4-Hydroxy-3-hydroxymethyl-alpha-((tert-butylamino)methyl)benzyl alcohol |
Combivent |
DL-N-tert-Butyl-2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethylamine |
alpha(sup 1)-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha-diol |
CHEBI:2549 |
Airomir |
Ventalin inhaler |
SCH-13949W |
NCGC00015955-09 |
Solbutamol |
(R)-Albuterol;(R)-Salbutamol;Levosalbutamol |
DSSTox_CID_1255 |
m-Xylene-alpha,alpha-diol, alpha-((tert-butylamino)methyl)-4-hydroxy- |
1,3-Benzenedimethanol, .alpha.1-(1,1-dimethylethyl)aminomethyl-4-hydroxy- |
4-{2-(1,1-dimethylethyl)amino-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
Albuterol (hemisulfate);AH-3365 (hemisulfate) |
DSSTox_RID_76042 |
DSSTox_GSID_21255 |
Salbutamolum INN-Latin |
Vospire |
Eolene |
4-{2-(tert-butyl)amino-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
Albuterol (USP) |
1219798-60-3 |
HSDB 7206 |
AH-3365 |
SR-01000075161 |
Albuterol USAN:USP |
EINECS 242-424-0 |
BRN 2213614 |
racemic salbutamol |
Salamol EB |
Albuterol-d3 |
Prestwick_665 |
CAS-18559-94-9 |
Salbutamol Free Base |
Salbutamol,(+/-) |
Venetlin (Salt/Mix) |
Spectrum_000200 |
Salbutamol INN:BAN |
Prestwick0_000198 |
Prestwick1_000198 |
Prestwick2_000198 |
Prestwick3_000198 |
Spectrum2_001350 |
Spectrum4_000887 |
Spectrum5_001059 |
m-Xylene-alpha,alpha-diol, alpha-((tert-butylamino)methyl)-4-hydroxy- |
CHEMBL714 |
1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy- |
EC 242-424-0 |
S 8260 |
SCHEMBL4913 |
Lopac0_001090 |
Lopac0_001098 |
BSPBio_000155 |
GTPL558 |
KBioGR_001294 |
KBioSS_000680 |
35763-26-9 |
DivK1c_000943 |
SPECTRUM1500677 |
SPBio_001539 |
SPBio_002076 |
BPBio1_000171 |
SGCUT00011 |
DTXSID5021255 |
SCHEMBL10025126 |
BCBcMAP01_000116 |
BDBM25769 |
HMS502P05 |
KBio1_000943 |
KBio2_000680 |
KBio2_003248 |
KBio2_005816 |
NINDS_000943 |
Bio1_000446 |
Bio1_000935 |
Bio1_001424 |
HMS1568H17 |
HMS1921C04 |
HMS2089I19 |
HMS2092I08 |
HMS2095H17 |
HMS3712H17 |
HMS3886I08 |
KUC106739N |
Pharmakon1600-01500677 |
SCH 13949W |
4-2-(tert-butylamino)-1-hydroxy-ethyl-2-(hydroxymethyl)phenol |
AMY38245 |
BCP28423 |
HY-B1037 |
Salbutamol-(tert-butyl-d9) acetate |
to_000081 |
Tox21_110266 |
Tox21_200800 |
CCG-39288 |
CS0015 |
NSC757417 |
PDSP1_000623 |
PDSP2_000620 |
s5494 |
SBB066105 |
AKOS007930174 |
Tox21_110266_1 |
CS-4556 |
DB01001 |
KS-5209 |
MCULE-4493408325 |
NSC 757417 |
NSC-757417 |
SB19749 |
SDCCGSBI-0051060.P006 |
1,3-Benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy- |
IDI1_000943 |
SMP1_000268 |
NCGC00015955-04 |
NCGC00015955-05 |
NCGC00015955-06 |
NCGC00015955-07 |
NCGC00015955-08 |
NCGC00015955-10 |
NCGC00015955-11 |
NCGC00015955-12 |
NCGC00015955-13 |
NCGC00015955-14 |
NCGC00015955-16 |
NCGC00015955-28 |
NCGC00024698-02 |
NCGC00024698-03 |
NCGC00024698-04 |
NCGC00024698-05 |
NCGC00024698-06 |
NCGC00024698-07 |
NCGC00258354-01 |
AC-10286 |
BA164143 |
KSC-11-222-1 |
Salbutamol 100 microg/mL in Acetonitrile |
ST024764 |
ST075204 |
ST077150 |
SBI-0051060.P005 |
AB0011383 |
AB00052154 |
EU-0101090 |
FT-0661467 |
FT-0770967 |
VU0243312-5 |
D02147 |
F15026 |
J10176 |
Salbutamol, VETRANAL(TM), analytical standard |
AB00052154-08 |
AB00052154-09 |
AB00052154_10 |
AB00052154_11 |
(+)-5,6-O-CYCLOHEXYLIDENE-L-ASCORBICACID |
559S949 |
A812971 |
L000531 |
Q410358 |
Q-201695 |
Q-201696 |
SR-01000075161-3 |
SR-01000075161-4 |
SR-01000075161-5 |
SR-01000075161-8 |
BRD-A88254928-001-04-6 |
BRD-A88254928-001-05-3 |
SR-01000075161-11 |
Salbutamol, British Pharmacopoeia (BP) Reference Standard |
Salbutamol, European Pharmacopoeia (EP) Reference Standard |
Albuterol, United States Pharmacopeia (USP) Reference Standard |
2-(tert-Butylamino)-1-4-hydroxy-3-(hydroxymethyl)phenylethanol |
4-2-(tert-Butylamino)-1-hydroxyethyl-2-(hydroxymethyl)phenol # |
4-2-(tert-butylamino)-1-oxidanyl-ethyl-2-(hydroxymethyl)phenol |
1-(tert-Butylaminomethyl)-4-hydroxy-m-xylene-.alpha.1,.alpha.3-diol |
4-(1S)-2-(butylamino)-1-hydroxy-isopropyl-2-(hydroxymethyl)phenol |
4-Hydroxy-3-hydroxymethyl-.alpha.-((tert-butylamino)methyl)benzyl alcohol |
.alpha.-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-.alpha.,.alpha.-diol" |
.alpha.1-(1,1-Dimethylethyl)aminomethyl-4-hydroxy-1,3-benzenedimethanol, hemisulfate" |
.alpha.1-(tert-Butylamino)methyl-4-hydroxy-m-xylene-.alpha.,.alpha.-diol |
1,3-Benzenedimethanol, .alpha.(1)-(1,1-dimethylethyl)aminomethyl-4-hydroxy- |
4-(1S)-1-hydroxy-2-(propylamino)ethyl-2-(hydroxymethyl)phenol, oxamethane |
m-Xylene-.alpha.,.alpha.-diol, .alpha.-((tert-butylamino)methyl)-4-hydroxy- |
m-Xylene-.alpha.,.alpha.-diol, .alpha.-1-((tert-butylamino)methyl)-4-hydroxy- |
148563-15-9 |
Experimental Data
Salbutamol
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 0 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Salbutamol
Statistics Data
Salbutamol
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 0 | 1 | 1 |
Statistics Data Visualization
Salbutamol
